US$ 23.78
glp-1 and graves disease Does Using Drugs, Like Zepbound or Wegovy, Increase Your Risk of Thyroid Cancer? Implications of GLP-1 Receptor Agonist
Description
95% CI: 3.27 to 0.39

2011;6:e26137

Rotate sites weekly to avoid lipohypertrophy (hard lumps under the skin)

95% CI, 0.75 to 1.32), whereas the use of GLP-1 analogues was linked to an increased risk (6.1 vs

Our implementation followed the original publication 17 , except that we excluded no regimen from the menu of treatment options and expanded the definition of injectables to include GLP-1 RA

Haines MS et al
